Aug 6 (Reuters) - Pfizer Inc agreed to pay $35 million to 41 U.S. states and Washington, D.C. to settle claims that its Wyeth unit illegally marketed the drug Rapamune, and encouraged doctors and hospitals to prescribe it for off-label uses.
The settlement was announced on Wednesday, just over one year after Pfizer agreed in July 2013 to pay $490.9 million to resolve U.S. Department of Justice claims over the marketing of the drug.
Pfizer bought Wyeth in October 2009, and the alleged improper conduct predated that purchase.
Help employers find you! Check out all the jobs and post your resume.
